Treatment with oral semaglutide (Rybelsus) significantly improved motivation measures in patients with major depressive ...

A newer brain stimulation therapy matched ECT for depression while causing less memory loss, offering a potential option for patients concerned about cognitive side effects.

While many brain-computer interface companies are focused on helping paralyzed people communicate, Motif Neurotech is ...

Scientists have identified two specific types of brain cells that behave differently in people with depression, offering a ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

Magnetic seizure therapy appeared to beneficial for the treatment of major depressive disorder with fewer memory-related risks.

Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of study ...

The FDA announced regulatory actions Friday to support development of serotonin-2A agonists and related products, including ...